Sep 8, 2026 07:29AM
Sep 8, 2026 07:29AM
Aug 16, 2026 08:05AM
Aug 5, 2026 10:40AM
Aug 3, 2026 09:00AM
Aug 3, 2026 09:00AM
Aug 3, 2026 08:32AM United Community Banks completes merger with Peach State Bancshares
Aug 3, 2026 08:30AM
Jul 21, 2026 07:29AM
Jul 10, 2026 09:01AM
Jul 10, 2026 09:01AM
Jul 8, 2026 09:02AM
Jun 17, 2026 07:52AM
Jun 17, 2026 07:00AM UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI® (doxecitine and doxribtimine) in Patients with Thymidine Kinase 2 Deficiency (TK2d)
Jun 12, 2026 09:21AM
Jun 12, 2026 09:20AM
Jun 12, 2026 07:30AM
Jun 12, 2026 07:30AM
Jun 1, 2026 11:11AM
May 19, 2026 03:14PM
May 3, 2026 08:00PM Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB
May 3, 2026 01:10PM
May 3, 2026 01:10PM
Apr 21, 2026 03:46PM
Apr 21, 2026 07:31AM
Apr 21, 2026 07:31AM
Apr 21, 2026 07:30AM
Apr 17, 2026 02:00PM UCB to acquire Neurona Therapeutics for up to $1.15 billion
Apr 17, 2026 02:00PM
Apr 15, 2026 07:00AM
Apr 13, 2026 07:00AM
Mar 27, 2026 09:00AM
Mar 27, 2026 09:00AM
Mar 24, 2026 02:46PM
Mar 11, 2026 07:00AM BIMZELX®▼(bimekizumab) superior to SKYRIZI® (risankizumab) in BE BOLD: first head-to-head study in active psoriatic arthritis (PsA) to demonstrate superiority in ACR50
Jan 15, 2026 09:03AM
Jan 14, 2026 07:30AM
Dec 8, 2025 07:00AM
Dec 8, 2025 07:00AM
Dec 4, 2025 08:12AM
Nov 3, 2025 04:00PM
Nov 3, 2025 04:00PM U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
Nov 3, 2025 04:00PM
Oct 31, 2025 01:04PM
Oct 29, 2025 12:00PM
Oct 29, 2025 07:00AM
Oct 25, 2025 11:00AM
Oct 23, 2025 09:12AM
Oct 22, 2025 07:30AM United Community Banks, Inc. Reports Third Quarter Earnings
Oct 14, 2025 07:10AM

1,187,957 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All